CN Patent

CN103570671B — 一种降糖化合物及其制法和应用

Assigned to SHANGHAI TIANCI INTERNATIONAL PHARMACEUTICAL Co.,Ltd. · Expires 2016-03-30 · 10y expired

What this patent protects

本发明公开了一种高效降糖化合物及其制法和应用。本发明的化合物，结构如式I所示，式中R 1 、R 2 、R 3 和R 4 的定义如说明书和权利要求书中所述。本发明还公开式I化合物的制备方法。本发明的式I化合物，对SGLT具有抑制活性，可有效用于预防或治疗与高血糖症有关的疾病。

USPTO Abstract

本发明公开了一种高效降糖化合物及其制法和应用。本发明的化合物，结构如式I所示，式中R 1 、R 2 、R 3 和R 4 的定义如说明书和权利要求书中所述。本发明还公开式I化合物的制备方法。本发明的式I化合物，对SGLT具有抑制活性，可有效用于预防或治疗与高血糖症有关的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN103570671B
Jurisdiction
CN
Classification
—
Expires
2016-03-30
Drug substance claim
No
Drug product claim
No
Assignee
SHANGHAI TIANCI INTERNATIONAL PHARMACEUTICAL Co.,Ltd.
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.